SlideShare a Scribd company logo
1 of 19
CIPLA INDUSTRIAL PRESENTATION
objective
 Founder of cipla
 What is cipla
 Location of head quarter & manufacturing of cipla
 history of cipla
 Salary details of employers
 Mission & vision
 Awards
 Financial stablity
K.A Hamied
is the founder
Of cipla
founder
• was born on october 31, 1898.
• got addmission in berlin university research
student of “technology of barium compounds.”
• he earned his doctorate of three years in 1972
• During to long voyage from europe to india,
he drew up great plans for the future.
•Today the cipla is a leading in anti-
infactive and anti-asthmatic formulation;
•Specilizes in the manufacturing of
steriods and harmones
•Cipla has time and earned the distinction
of coming out pioneering and life saving
drugs.
WHATIS CIPLA
Cipla Limited
Industry Pharmaceuticals
Founded 1935
Founder Dr. K. A. Hamied
Headquarters Mumbai, Maharashtra
Area served Worldwide
Key people Y. K. Hamied, Chairman
Umang Vohra (CEO)
Products Pharmaceuticals and diagnostics
Number of employees 22,036
CiplaLtd.
CiplaHouse, PeninsulaBusinessPark
Ganpatrao Kadam Marg
LowerParel,Mumbai– 400013
Tel:+9122 24826000, 24826701
Email:productqueries@cipla.com
location of cipla head quarter
LOCATION OF MANUFACTURING OF CIPLA
 House No 5-9-286/2/59, Kukatpally, Hyderabad - 500072,
IDA Rajiv Gandhi Nagar Prashanth Nagar

, +(91)-22-32000055
 1800229898
 +(91)-40-23075830
 1990-this year company launched several product like
1] aerocart 2] narfox eyelear drop.
1992-this year company launched –(1) cipril & felogard tablets
for hypertension
2000—cipla and ranbaxy labratories have expanded an
exesting partnership by adding one more new drug co-
marketting arrengement
2004—cipla done arrangement with marton groove
pharmaceuticals is far entertaining us market
2009—it launched anti malaria
Salary detail of employers
worker Monthly salary Yearly salary
Territory manager 27,200 3,54,400
Management staff 79,0oo 9,48,500
Medical representative 23,400 2,97,600
Project manager 1,30,800 15,70,100
Senior manager 98,600 11,83,300
Management staff in cipla 30,700 3,69,300
Business manager 88,800 10,65,100
IMPORTANT CONSUMER PRODUCTS
 Alzheimer’s dementia
 Anabolic
 Anti-TB drugs
 Antifungal
 Cough and cold
 Diaretics
 Iron checlators
 Four derm
 Respiratory drugs… Etc
awards
 In 2012, Cipla received the Thomson Reuters India
Innovation Award.
 Cipla won Dun & Bradstreet American Express
Corporate Awards for 2006.
 In 2005, Forbes included Cipla in the 200 'Best under a
billion' list of best small Asian companies.
 In 1980, Cipla won Chemexcil Award for Excellence for
exports.
 Cipla stood third in the India's Most Reputed
Brands (Pharmaceutical) list in a study conducted by
BlueBytes, a leading Media Analytics firm in
association with TRA Research,a brand insights
organization (both a part of the Comniscient Group).
FINANCIAL STABLITY
 Last year the india actual growth was around 9%
 The total domestic market grew by 15% according to org-ims statistics
 The cipla company turn over at rs4429 crore crossed the USD 1 billion mark for the
first time
 Inspite of the sluggish start in the first quarter the over all turnover of the company
grew by 18%
 The earning of cilpa on account of technology fees crossed rs 150 crore
Thank You So Much
For Your Attention
-
prepared by nadeem

More Related Content

What's hot (20)

Lupin
LupinLupin
Lupin
 
OS FINAL
OS FINALOS FINAL
OS FINAL
 
Strategy Analysis of Titan
Strategy Analysis of  TitanStrategy Analysis of  Titan
Strategy Analysis of Titan
 
Presentation on cipla project
Presentation on cipla projectPresentation on cipla project
Presentation on cipla project
 
HUL PRODUCT MIX
HUL PRODUCT MIXHUL PRODUCT MIX
HUL PRODUCT MIX
 
ppt
pptppt
ppt
 
Sun pharma ppt
Sun pharma pptSun pharma ppt
Sun pharma ppt
 
Dabur product mix
Dabur product mixDabur product mix
Dabur product mix
 
Pharmaceutical industry India
Pharmaceutical industry IndiaPharmaceutical industry India
Pharmaceutical industry India
 
A project report on dabur
A project report on daburA project report on dabur
A project report on dabur
 
Biocon Company Profile
Biocon Company ProfileBiocon Company Profile
Biocon Company Profile
 
Dr. Reddy's Lab - Business Model
Dr. Reddy's Lab - Business ModelDr. Reddy's Lab - Business Model
Dr. Reddy's Lab - Business Model
 
Indian Pharma Industry
Indian Pharma IndustryIndian Pharma Industry
Indian Pharma Industry
 
Sun Pharma Vs Lupin Pharma
Sun Pharma Vs Lupin PharmaSun Pharma Vs Lupin Pharma
Sun Pharma Vs Lupin Pharma
 
DR REDDYS LABS PPT
DR REDDYS LABS PPTDR REDDYS LABS PPT
DR REDDYS LABS PPT
 
Sun Pharma
Sun Pharma Sun Pharma
Sun Pharma
 
Hul
HulHul
Hul
 
Himalaya ppt
Himalaya pptHimalaya ppt
Himalaya ppt
 
HINDUSTAN UNILEVER LIMITED PPT
HINDUSTAN UNILEVER LIMITED PPT HINDUSTAN UNILEVER LIMITED PPT
HINDUSTAN UNILEVER LIMITED PPT
 
Britannia Project Report
Britannia Project Report Britannia Project Report
Britannia Project Report
 

Similar to Cipla presentation

5 different Entrepreneurship company
 5 different Entrepreneurship company 5 different Entrepreneurship company
5 different Entrepreneurship companyjain university
 
Comparative Time line analysis of Indian Pharmaceutical Industry
Comparative Time line analysis of Indian Pharmaceutical  Industry  Comparative Time line analysis of Indian Pharmaceutical  Industry
Comparative Time line analysis of Indian Pharmaceutical Industry AMAR SHAKTI KUMAR
 
P & G ( Procter & Gamble ) Tide :- Marketing Management
P & G ( Procter & Gamble ) Tide :- Marketing ManagementP & G ( Procter & Gamble ) Tide :- Marketing Management
P & G ( Procter & Gamble ) Tide :- Marketing ManagementSanchit
 
biocon & ms.shaw
biocon & ms.shawbiocon & ms.shaw
biocon & ms.shawleo
 
IU2284000007_TWESHA_IMBA.pdf
IU2284000007_TWESHA_IMBA.pdfIU2284000007_TWESHA_IMBA.pdf
IU2284000007_TWESHA_IMBA.pdfkSaiyam1
 
Successful entrepreneur (kiran muzumdar shaw) by sai
Successful entrepreneur (kiran muzumdar shaw) by saiSuccessful entrepreneur (kiran muzumdar shaw) by sai
Successful entrepreneur (kiran muzumdar shaw) by saisai guntapelliwar
 
1st annual pharmaceutical leadership summit
1st annual pharmaceutical leadership summit1st annual pharmaceutical leadership summit
1st annual pharmaceutical leadership summitIndian Affairs
 
1st annual pharmaceutical leadership summit
1st annual pharmaceutical leadership summit1st annual pharmaceutical leadership summit
1st annual pharmaceutical leadership summitpharmaleaders
 
Working capital management of Jubilant Life Sciences (2)
Working capital management of Jubilant Life Sciences (2)Working capital management of Jubilant Life Sciences (2)
Working capital management of Jubilant Life Sciences (2)Utsav Randev
 
Bioentrepreneurs of india
Bioentrepreneurs of indiaBioentrepreneurs of india
Bioentrepreneurs of indiasnjogdand
 
Spirit of manufacturing II
Spirit of manufacturing IISpirit of manufacturing II
Spirit of manufacturing IIPower2SME
 
Leading Medtech Companies 2022 (1).pdf
Leading Medtech Companies 2022 (1).pdfLeading Medtech Companies 2022 (1).pdf
Leading Medtech Companies 2022 (1).pdfCIOLOOKIndia
 
Corportate Entrepreneurship at WIPRO
Corportate Entrepreneurship at WIPROCorportate Entrepreneurship at WIPRO
Corportate Entrepreneurship at WIPRONeil Mathew
 

Similar to Cipla presentation (20)

5 different Entrepreneurship company
 5 different Entrepreneurship company 5 different Entrepreneurship company
5 different Entrepreneurship company
 
Comparative Time line analysis of Indian Pharmaceutical Industry
Comparative Time line analysis of Indian Pharmaceutical  Industry  Comparative Time line analysis of Indian Pharmaceutical  Industry
Comparative Time line analysis of Indian Pharmaceutical Industry
 
Dr kiranmazumdarshaw
Dr kiranmazumdarshawDr kiranmazumdarshaw
Dr kiranmazumdarshaw
 
P & G ( Procter & Gamble ) Tide :- Marketing Management
P & G ( Procter & Gamble ) Tide :- Marketing ManagementP & G ( Procter & Gamble ) Tide :- Marketing Management
P & G ( Procter & Gamble ) Tide :- Marketing Management
 
biocon & ms.shaw
biocon & ms.shawbiocon & ms.shaw
biocon & ms.shaw
 
INTERNSHIP Presentation
INTERNSHIP PresentationINTERNSHIP Presentation
INTERNSHIP Presentation
 
IU2284000007_TWESHA_IMBA.pdf
IU2284000007_TWESHA_IMBA.pdfIU2284000007_TWESHA_IMBA.pdf
IU2284000007_TWESHA_IMBA.pdf
 
Presentation on CIPLA
Presentation on CIPLA Presentation on CIPLA
Presentation on CIPLA
 
Cipla
CiplaCipla
Cipla
 
Successful entrepreneur (kiran muzumdar shaw) by sai
Successful entrepreneur (kiran muzumdar shaw) by saiSuccessful entrepreneur (kiran muzumdar shaw) by sai
Successful entrepreneur (kiran muzumdar shaw) by sai
 
1st annual pharmaceutical leadership summit
1st annual pharmaceutical leadership summit1st annual pharmaceutical leadership summit
1st annual pharmaceutical leadership summit
 
1st annual pharmaceutical leadership summit
1st annual pharmaceutical leadership summit1st annual pharmaceutical leadership summit
1st annual pharmaceutical leadership summit
 
Working capital management of Jubilant Life Sciences (2)
Working capital management of Jubilant Life Sciences (2)Working capital management of Jubilant Life Sciences (2)
Working capital management of Jubilant Life Sciences (2)
 
Brady Bio
Brady BioBrady Bio
Brady Bio
 
Bioentrepreneurs of india
Bioentrepreneurs of indiaBioentrepreneurs of india
Bioentrepreneurs of india
 
ipr_3rd_sem
ipr_3rd_semipr_3rd_sem
ipr_3rd_sem
 
Spirit of manufacturing II
Spirit of manufacturing IISpirit of manufacturing II
Spirit of manufacturing II
 
Leading Medtech Companies 2022 (1).pdf
Leading Medtech Companies 2022 (1).pdfLeading Medtech Companies 2022 (1).pdf
Leading Medtech Companies 2022 (1).pdf
 
Corportate Entrepreneurship at WIPRO
Corportate Entrepreneurship at WIPROCorportate Entrepreneurship at WIPRO
Corportate Entrepreneurship at WIPRO
 
Catalogue baby
Catalogue babyCatalogue baby
Catalogue baby
 

Recently uploaded

Expanded definition: technical and operational
Expanded definition: technical and operationalExpanded definition: technical and operational
Expanded definition: technical and operationalssuser3e220a
 
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdfGrade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdfJemuel Francisco
 
Active Learning Strategies (in short ALS).pdf
Active Learning Strategies (in short ALS).pdfActive Learning Strategies (in short ALS).pdf
Active Learning Strategies (in short ALS).pdfPatidar M
 
ICS 2208 Lecture Slide Notes for Topic 6
ICS 2208 Lecture Slide Notes for Topic 6ICS 2208 Lecture Slide Notes for Topic 6
ICS 2208 Lecture Slide Notes for Topic 6Vanessa Camilleri
 
Congestive Cardiac Failure..presentation
Congestive Cardiac Failure..presentationCongestive Cardiac Failure..presentation
Congestive Cardiac Failure..presentationdeepaannamalai16
 
4.11.24 Poverty and Inequality in America.pptx
4.11.24 Poverty and Inequality in America.pptx4.11.24 Poverty and Inequality in America.pptx
4.11.24 Poverty and Inequality in America.pptxmary850239
 
Concurrency Control in Database Management system
Concurrency Control in Database Management systemConcurrency Control in Database Management system
Concurrency Control in Database Management systemChristalin Nelson
 
Q4-PPT-Music9_Lesson-1-Romantic-Opera.pptx
Q4-PPT-Music9_Lesson-1-Romantic-Opera.pptxQ4-PPT-Music9_Lesson-1-Romantic-Opera.pptx
Q4-PPT-Music9_Lesson-1-Romantic-Opera.pptxlancelewisportillo
 
CLASSIFICATION OF ANTI - CANCER DRUGS.pptx
CLASSIFICATION OF ANTI - CANCER DRUGS.pptxCLASSIFICATION OF ANTI - CANCER DRUGS.pptx
CLASSIFICATION OF ANTI - CANCER DRUGS.pptxAnupam32727
 
MS4 level being good citizen -imperative- (1) (1).pdf
MS4 level   being good citizen -imperative- (1) (1).pdfMS4 level   being good citizen -imperative- (1) (1).pdf
MS4 level being good citizen -imperative- (1) (1).pdfMr Bounab Samir
 
How to Fix XML SyntaxError in Odoo the 17
How to Fix XML SyntaxError in Odoo the 17How to Fix XML SyntaxError in Odoo the 17
How to Fix XML SyntaxError in Odoo the 17Celine George
 
4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptx4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptxmary850239
 
Mythology Quiz-4th April 2024, Quiz Club NITW
Mythology Quiz-4th April 2024, Quiz Club NITWMythology Quiz-4th April 2024, Quiz Club NITW
Mythology Quiz-4th April 2024, Quiz Club NITWQuiz Club NITW
 
4.16.24 21st Century Movements for Black Lives.pptx
4.16.24 21st Century Movements for Black Lives.pptx4.16.24 21st Century Movements for Black Lives.pptx
4.16.24 21st Century Movements for Black Lives.pptxmary850239
 
Q-Factor General Quiz-7th April 2024, Quiz Club NITW
Q-Factor General Quiz-7th April 2024, Quiz Club NITWQ-Factor General Quiz-7th April 2024, Quiz Club NITW
Q-Factor General Quiz-7th April 2024, Quiz Club NITWQuiz Club NITW
 
4.11.24 Mass Incarceration and the New Jim Crow.pptx
4.11.24 Mass Incarceration and the New Jim Crow.pptx4.11.24 Mass Incarceration and the New Jim Crow.pptx
4.11.24 Mass Incarceration and the New Jim Crow.pptxmary850239
 
Grade Three -ELLNA-REVIEWER-ENGLISH.pptx
Grade Three -ELLNA-REVIEWER-ENGLISH.pptxGrade Three -ELLNA-REVIEWER-ENGLISH.pptx
Grade Three -ELLNA-REVIEWER-ENGLISH.pptxkarenfajardo43
 
ARTERIAL BLOOD GAS ANALYSIS........pptx
ARTERIAL BLOOD  GAS ANALYSIS........pptxARTERIAL BLOOD  GAS ANALYSIS........pptx
ARTERIAL BLOOD GAS ANALYSIS........pptxAneriPatwari
 
Scientific Writing :Research Discourse
Scientific  Writing :Research  DiscourseScientific  Writing :Research  Discourse
Scientific Writing :Research DiscourseAnita GoswamiGiri
 

Recently uploaded (20)

Expanded definition: technical and operational
Expanded definition: technical and operationalExpanded definition: technical and operational
Expanded definition: technical and operational
 
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdfGrade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
 
Active Learning Strategies (in short ALS).pdf
Active Learning Strategies (in short ALS).pdfActive Learning Strategies (in short ALS).pdf
Active Learning Strategies (in short ALS).pdf
 
ICS 2208 Lecture Slide Notes for Topic 6
ICS 2208 Lecture Slide Notes for Topic 6ICS 2208 Lecture Slide Notes for Topic 6
ICS 2208 Lecture Slide Notes for Topic 6
 
Congestive Cardiac Failure..presentation
Congestive Cardiac Failure..presentationCongestive Cardiac Failure..presentation
Congestive Cardiac Failure..presentation
 
4.11.24 Poverty and Inequality in America.pptx
4.11.24 Poverty and Inequality in America.pptx4.11.24 Poverty and Inequality in America.pptx
4.11.24 Poverty and Inequality in America.pptx
 
Concurrency Control in Database Management system
Concurrency Control in Database Management systemConcurrency Control in Database Management system
Concurrency Control in Database Management system
 
INCLUSIVE EDUCATION PRACTICES FOR TEACHERS AND TRAINERS.pptx
INCLUSIVE EDUCATION PRACTICES FOR TEACHERS AND TRAINERS.pptxINCLUSIVE EDUCATION PRACTICES FOR TEACHERS AND TRAINERS.pptx
INCLUSIVE EDUCATION PRACTICES FOR TEACHERS AND TRAINERS.pptx
 
Q4-PPT-Music9_Lesson-1-Romantic-Opera.pptx
Q4-PPT-Music9_Lesson-1-Romantic-Opera.pptxQ4-PPT-Music9_Lesson-1-Romantic-Opera.pptx
Q4-PPT-Music9_Lesson-1-Romantic-Opera.pptx
 
CLASSIFICATION OF ANTI - CANCER DRUGS.pptx
CLASSIFICATION OF ANTI - CANCER DRUGS.pptxCLASSIFICATION OF ANTI - CANCER DRUGS.pptx
CLASSIFICATION OF ANTI - CANCER DRUGS.pptx
 
MS4 level being good citizen -imperative- (1) (1).pdf
MS4 level   being good citizen -imperative- (1) (1).pdfMS4 level   being good citizen -imperative- (1) (1).pdf
MS4 level being good citizen -imperative- (1) (1).pdf
 
How to Fix XML SyntaxError in Odoo the 17
How to Fix XML SyntaxError in Odoo the 17How to Fix XML SyntaxError in Odoo the 17
How to Fix XML SyntaxError in Odoo the 17
 
4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptx4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptx
 
Mythology Quiz-4th April 2024, Quiz Club NITW
Mythology Quiz-4th April 2024, Quiz Club NITWMythology Quiz-4th April 2024, Quiz Club NITW
Mythology Quiz-4th April 2024, Quiz Club NITW
 
4.16.24 21st Century Movements for Black Lives.pptx
4.16.24 21st Century Movements for Black Lives.pptx4.16.24 21st Century Movements for Black Lives.pptx
4.16.24 21st Century Movements for Black Lives.pptx
 
Q-Factor General Quiz-7th April 2024, Quiz Club NITW
Q-Factor General Quiz-7th April 2024, Quiz Club NITWQ-Factor General Quiz-7th April 2024, Quiz Club NITW
Q-Factor General Quiz-7th April 2024, Quiz Club NITW
 
4.11.24 Mass Incarceration and the New Jim Crow.pptx
4.11.24 Mass Incarceration and the New Jim Crow.pptx4.11.24 Mass Incarceration and the New Jim Crow.pptx
4.11.24 Mass Incarceration and the New Jim Crow.pptx
 
Grade Three -ELLNA-REVIEWER-ENGLISH.pptx
Grade Three -ELLNA-REVIEWER-ENGLISH.pptxGrade Three -ELLNA-REVIEWER-ENGLISH.pptx
Grade Three -ELLNA-REVIEWER-ENGLISH.pptx
 
ARTERIAL BLOOD GAS ANALYSIS........pptx
ARTERIAL BLOOD  GAS ANALYSIS........pptxARTERIAL BLOOD  GAS ANALYSIS........pptx
ARTERIAL BLOOD GAS ANALYSIS........pptx
 
Scientific Writing :Research Discourse
Scientific  Writing :Research  DiscourseScientific  Writing :Research  Discourse
Scientific Writing :Research Discourse
 

Cipla presentation

  • 2. objective  Founder of cipla  What is cipla  Location of head quarter & manufacturing of cipla  history of cipla  Salary details of employers  Mission & vision  Awards  Financial stablity
  • 3. K.A Hamied is the founder Of cipla
  • 4. founder • was born on october 31, 1898. • got addmission in berlin university research student of “technology of barium compounds.” • he earned his doctorate of three years in 1972 • During to long voyage from europe to india, he drew up great plans for the future.
  • 5. •Today the cipla is a leading in anti- infactive and anti-asthmatic formulation; •Specilizes in the manufacturing of steriods and harmones •Cipla has time and earned the distinction of coming out pioneering and life saving drugs. WHATIS CIPLA
  • 6. Cipla Limited Industry Pharmaceuticals Founded 1935 Founder Dr. K. A. Hamied Headquarters Mumbai, Maharashtra Area served Worldwide Key people Y. K. Hamied, Chairman Umang Vohra (CEO) Products Pharmaceuticals and diagnostics Number of employees 22,036
  • 7. CiplaLtd. CiplaHouse, PeninsulaBusinessPark Ganpatrao Kadam Marg LowerParel,Mumbai– 400013 Tel:+9122 24826000, 24826701 Email:productqueries@cipla.com location of cipla head quarter
  • 8. LOCATION OF MANUFACTURING OF CIPLA  House No 5-9-286/2/59, Kukatpally, Hyderabad - 500072, IDA Rajiv Gandhi Nagar Prashanth Nagar  , +(91)-22-32000055  1800229898  +(91)-40-23075830
  • 9.  1990-this year company launched several product like 1] aerocart 2] narfox eyelear drop. 1992-this year company launched –(1) cipril & felogard tablets for hypertension 2000—cipla and ranbaxy labratories have expanded an exesting partnership by adding one more new drug co- marketting arrengement 2004—cipla done arrangement with marton groove pharmaceuticals is far entertaining us market 2009—it launched anti malaria
  • 10. Salary detail of employers worker Monthly salary Yearly salary Territory manager 27,200 3,54,400 Management staff 79,0oo 9,48,500 Medical representative 23,400 2,97,600 Project manager 1,30,800 15,70,100 Senior manager 98,600 11,83,300 Management staff in cipla 30,700 3,69,300 Business manager 88,800 10,65,100
  • 11.
  • 12.
  • 13.
  • 14. IMPORTANT CONSUMER PRODUCTS  Alzheimer’s dementia  Anabolic  Anti-TB drugs  Antifungal  Cough and cold  Diaretics  Iron checlators  Four derm  Respiratory drugs… Etc
  • 15.
  • 16.
  • 17. awards  In 2012, Cipla received the Thomson Reuters India Innovation Award.  Cipla won Dun & Bradstreet American Express Corporate Awards for 2006.  In 2005, Forbes included Cipla in the 200 'Best under a billion' list of best small Asian companies.  In 1980, Cipla won Chemexcil Award for Excellence for exports.  Cipla stood third in the India's Most Reputed Brands (Pharmaceutical) list in a study conducted by BlueBytes, a leading Media Analytics firm in association with TRA Research,a brand insights organization (both a part of the Comniscient Group).
  • 18. FINANCIAL STABLITY  Last year the india actual growth was around 9%  The total domestic market grew by 15% according to org-ims statistics  The cipla company turn over at rs4429 crore crossed the USD 1 billion mark for the first time  Inspite of the sluggish start in the first quarter the over all turnover of the company grew by 18%  The earning of cilpa on account of technology fees crossed rs 150 crore
  • 19. Thank You So Much For Your Attention - prepared by nadeem